A Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy Subject

NCT01737931 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Otsuka Pharmaceutical Co., Ltd.